Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide delivered by subcutaneous injection works through a precise mechanism: the medication must reach the adipose tissue layer beneath your skin to trigger GLP-1 receptor activation in your gastrointestinal system. Mastering injection technique and site selection ensures you receive consistent medication delivery and maximize therapeutic benefits. PlexusDx supports patients on compounded semaglutide with evidence-based injection education to help you administer your weekly dose with confidence.

Proper Semaglutide Injection Technique and Needle Depth

Subcutaneous injection means placing medication into the layer of tissue between your skin and muscle—not into muscle itself (intramuscular) and not into a blood vessel. Clinical data shows that subcutaneous delivery of semaglutide produces consistent absorption rates and predictable clinical response. To inject correctly, pinch the skin at your chosen site to create a fold, insert the needle at a 90-degree angle (perpendicular to the skin), and inject slowly over 3–5 seconds. After injection, release the skin fold and wait 10 seconds before removing the needle to prevent backflow.

Needle depth matters because semaglutide requires contact with subcutaneous adipose tissue to be absorbed properly. Most semaglutide pens and auto-injectors use 4–5 millimeter needles, which is appropriate for patients with average to higher body weight. If you have very little subcutaneous tissue, consult your PlexusDx provider about needle length; injecting into muscle can cause faster absorption and unpredictable blood glucose effects. Never reuse needles, as they become dull, increase injection pain, and risk tissue damage.

Best Injection Sites for Semaglutide Administration

The FDA-approved injection sites for semaglutide include the abdomen, thigh, and upper arm—areas with reliable subcutaneous fat padding. The abdomen (belly area, at least 2 inches from the navel) offers the largest injection surface and consistent absorption. The anterior and lateral thigh provides good access for self-injection and adequate tissue depth. The back of the upper arm is appropriate if someone else administers your injection or if you can reach it comfortably. Rotating between these three body regions reduces the risk of lipohypertrophy—thickening of fat tissue that can develop from repeated injections in the same spot.

Absorption rates vary slightly by location: abdominal injections typically produce slightly faster absorption than thigh or arm injections, though all three sites remain clinically acceptable. Avoid injecting into areas with scars, bruises, hardened skin, or active inflammation. If you notice redness, warmth, or a lump at previous injection sites, skip that area for at least two weeks and notify your PlexusDx provider. Consistent rotation prevents the buildup of scar tissue and maintains uniform medication delivery across weeks.

Site Rotation Schedules and Injection Interval Management

A simple rotation pattern reduces injection site complications and maintains steady therapeutic levels. One effective schedule: Week 1 inject the right abdomen, Week 2 the left abdomen, Week 3 the right thigh, Week 4 the left thigh, then repeat. This four-week cycle ensures each site receives rest between injections and prevents lipohypertrophy. Alternatively, you may rotate within the same body region each week (e.g., different spots within the abdomen) if you prefer. The key principle is never using the exact same injection site twice within a four-week period.

Since compounded semaglutide is administered once weekly, your rotation schedule naturally spaces injections across different areas. Track your injection sites using a simple calendar or smartphone note to avoid repeated spots. If you accidentally inject the same site twice, simply resume your rotation pattern the following week—one overlap does not cause harm. Maintaining consistent timing (injecting on the same day each week) combined with site rotation optimizes absorption stability and reduces the variable side effects that stem from unpredictable delivery patterns.

Genetic Factors and Personalized Injection Planning with PlexusDx

Your genetic makeup influences how your body processes semaglutide, which may affect how you experience injection-site reactions and overall medication tolerance. PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and identifies key variants in your GLP1R gene (rs6923761), GIPR pathway (rs1800437), and MC4R receptor (rs17782313)—all relevant to how your tissues respond to GLP-1 therapy. Patients with certain genetic predispositions may experience more skin sensitivity at injection sites or require adjusted injection spacing. After your first month of treatment, the genetic test costs $99 and provides insights to personalize your injection approach.

Understanding your peptide-pathway genetics helps PlexusDx providers recommend the best injection site strategy and potential modifications if you develop sensitivity. For example, individuals with specific FTO gene variants (rs9939609) may benefit from consistent abdominal injections due to differential adipose tissue responsiveness. The Precision Peptide Genetic Test analyzes 150+ genetic insights across 49 peptides, enabling truly personalized guidance that generic injection instructions cannot provide. This data-driven approach transforms semaglutide therapy from a one-size-fits-all protocol into a tailored plan matched to your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into my abdomen every week, or do I have to rotate sites?

Site rotation is strongly recommended to prevent lipohypertrophy and maintain consistent absorption. While abdominal injections are convenient, using the same spot repeatedly can cause fat tissue thickening or hardening, which disrupts medication delivery. PlexusDx recommends rotating among abdomen, thigh, and upper arm on a four-week cycle to ensure your dose stays effective and side effects remain predictable.

What happens if I inject semaglutide into muscle instead of subcutaneous fat?

Intramuscular injection can lead to faster, unpredictable absorption and variable blood glucose effects that make your response difficult to manage. Subcutaneous delivery—into the fat layer between skin and muscle—is required for the steady, sustained GLP-1 activation that semaglutide is designed to provide. Always pinch the skin and use a 90-degree needle angle to ensure you reach subcutaneous tissue, not muscle.

How much does compounded semaglutide cost at PlexusDx, and does price change with dose adjustments?

PlexusDx compounded semaglutide injection starts at $149 per month across all three commitment tiers. Your dose may need to go up over time as your body adjusts, but your price won't increase—you pay a flat monthly rate. All medications come from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible for additional savings.

Is it normal to feel pain or see bruising at semaglutide injection sites?

Mild stinging during injection is common and typically resolves within seconds. Bruising may occur if a small blood vessel is nicked, but it fades within 1–2 weeks and is not dangerous. However, persistent redness, warmth, swelling, or lumps suggest an infection or lipohypertrophy and require medical attention. Skip that injection site for two weeks and contact your PlexusDx provider if symptoms continue.

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide injection planning?

The test ($99 after your first month of treatment) identifies your GLP1R, GIPR, FTO, and MC4R genetic variants—all relevant to how your tissues respond to semaglutide. This information helps PlexusDx providers personalize your injection site strategy, predict injection-site sensitivity, and optimize your overall therapy plan. Understanding your peptide-pathway genetics enables precision recommendations beyond standard injection guidance.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves